Your browser doesn't support javascript.
loading
The efficacy and safety of adding on or switching to peginterferon α-2b in HBeAg-positive chronic hepatitis B patients with long-term entecavir treatment: a multicentre randomised controlled trial.
Hu, Qiankun; Qi, Xun; Yu, Yiqi; Gao, Yueqiu; Zhang, Xinxin; Wang, Qianqian; Zhang, Xueyun; Zhuo, Yunhui; Li, Jing; Zhang, Jiming; Chen, Liang; Huang, Yuxian.
Afiliação
  • Hu Q; Department of Liver Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Qi X; Department of Liver Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Yu Y; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Gao Y; Department of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Zhang X; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Wang Q; Department of Liver Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Zhang X; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Zhuo Y; Department of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Li J; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Zhang J; Department of Infectious Diseases, Shanghai Key Laboratory of Infectious Diseases and Biosafety Emergency Response, National Medical Center for Infectious Diseases, Huashan Hospital, Fudan University, Shanghai, China.
  • Chen L; Department of Liver Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Huang Y; Department of Liver Diseases, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Aliment Pharmacol Ther ; 56(9): 1394-1407, 2022 11.
Article em En | MEDLINE | ID: mdl-36128636
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Antígenos E da Hepatite B Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Aliment Pharmacol Ther Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Base de dados: MEDLINE Assunto principal: Hepatite B Crônica / Antígenos E da Hepatite B Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Aliment Pharmacol Ther Ano de publicação: 2022 Tipo de documento: Article